Interpace Pharma Solutions Announces New Advanced Offering in RNA Biomarker AnalysisGlobeNewsWire • 04/12/21
Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thyroid Assay, ThyGeNEXT®GlobeNewsWire • 04/05/21
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business ResultsGlobeNewsWire • 03/31/21
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of IllinoisGlobeNewsWire • 02/25/21
Interpace Biosciences Announces License Agreement with Rutgers University and Mass General HospitalGlobeNewsWire • 02/01/21
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of FloridaGlobeNewsWire • 01/28/21
Interpace Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, January 21, 2021GlobeNewsWire • 01/20/21
Interpace Biosciences Announces Third Quarter 2020 Financial and Business Results and Completion of $5 Million Bridge LoanGlobeNewsWire • 01/20/21
Interpace Biosciences Announces Executive Transition: Jack Stover to Retire as President and Chief Executive Officer Thomas Burnell Appointed as SuccessorGlobeNewsWire • 11/25/20
Interpace Biosciences Receives Nasdaq Deficiency Notice Due to Delayed Filing of Form 10-Q; No Immediate Impact on ListingGlobeNewsWire • 11/19/20
Interpace Biosciences Announces Results of Seminal Clinical Validation Study for Thyroid AssaysGlobeNewsWire • 10/26/20
Interpace Biosciences Announces Second Quarter 2020 Financial and Business ResultsGlobeNewsWire • 10/20/20
Interpace Biosciences’ Audit Committee Investigation Finds Complaints UnsubstantiatedGlobeNewsWire • 10/14/20
Interpace Announces Acceptance of Seminal Clinical Validation Study for Thyroid AssaysGlobeNewsWire • 07/21/20
Interpace Biosciences, Inc. (IDXG) CEO Jack Stover on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 06/25/20
Interpace Biosciences Announces First Quarter 2020 Financial and Business ResultsGlobeNewsWire • 06/25/20
Interpace Biosciences Announces Full Year and Fourth Quarter 2019 Financial and Business Results and Preliminary Q1-2020 ResultsGlobeNewsWire • 04/22/20